Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on WANDISCO PLC. We currently have 29 research reports from 4 professional analysts.
|08Mar17 07:00||RNS||Preliminary Results|
|06Mar17 16:40||RNS||Second Price Monitoring Extn|
|06Mar17 16:35||RNS||Price Monitoring Extension|
|23Feb17 07:00||RNS||Board Update|
|14Feb17 07:00||RNS||Notice of Results and Investor Presentation|
|18Jan17 16:40||RNS||Second Price Monitoring Extn|
|18Jan17 16:35||RNS||Price Monitoring Extension|
Frequency of research reports
Research reports on
In a good place
21 Mar 17
WANdisco’s full year results confirmed the strong recovery in H2. We believe this is set to continue, driven by the company’s enviable exposure to the growth in cloud computing and partnerships with industry giants such as IBM, Amazon and Oracle. We suggest that the ingredients could be in place to support a more aggressive break out in financial performance than forecast, although the share price does demand this.
Good progress across 2016
26 Jan 17
Following our notes on WANdisco in July and August (which focused on the IBM relationship and the Smart City deal) this brief comment summarises how the group has fared during 2016 and sets the scene for 2017. Alongside the major agreement with IBM, WANdisco produced encouraging interim results, announced significant contract wins and raised new equity. We highlight good arket engagement in the form of new contracts and note the record bookings and excellent progress towards its target of neutralising the monthly cash burn during Q4. The group ended 2016 with net cash of U$7.6 million, a strong order book and good sales pipeline.
23 Jan 17
WANdisco’s performance in H2 indicates that its investment in creating a platform for scalable growth is starting to reap returns. H2 bookings grew by 109%, costs reduced and in Q4 the company operated at close to cash-flow break even. The pipeline entering FY17 is strong and with three major tech partners – IBM, Oracle and Amazon – now generating sales, WANdisco looks exceptionally well placed to continue benefitting from the growth in cloud storage and big data.
N+1 Singer - IQE - Upgrade cycle set to continue
24 Mar 17
IQE’s FY’16 results showed good growth in all key segments and came in c.4% ahead of our recently upgraded forecasts. We have upgraded our forecasts today by 5% and 3% in FY’17 and FY’18 respectively, but expect the upgrade cycle to continue. The increase in capex in FY’16 looks to us a strong indication of future volume increases, and we see scope for significant upgrades through the course of our forecast horizon. We highlight three opportunities in this note, each of which could materially move the needle in its own right. IQE is one of our key picks for 2017 and has performed strongly YTD (+48%), but we believe there is more to go for. We increase our target price to 76p and retain our Buy recommendation.
Photonics the star of the show
21 Mar 17
IQE’s diversification strategy delivered a 17% jump in adjusted profit before tax during FY16. Strong growth in photonics revenues was a key element of this improvement. This was boosted by a return to growth, albeit modest, in the wireless sector and weak sterling. We revise our FY17 estimates upwards to reflect the progress made on customer qualifications for photonics applications, and we introduce FY18 estimates.
Stronger and stronger
23 Mar 17
Sopheon has reported strong prelims in line with the January trading update which had demonstrated that revenue delivery had been achieved on cost underspend, leading to EBITDA (+7% vs FY16E) and adjusted PBT (+22%) outperformance. Strong licence sales, high levels of recurring revenue retention (94% by value), and ever upgrading product portfolio in terms of functionality delivered revenue strength. Gartner recognition illustrates the transition from a product which needed to be described then sold, to a solution set sought by customers to deal with the increasingly acknowledged enterprise problem of efficient product lifecycle management. Sopheon is well positioned for future growth, and board confidence for future growth leads to planned increase in investment, yet still delivering $5.6m ($5.3m pre FX) EBITDA. Having smashed through our FY16 forecasts and target price, we restore FY17 forecasts and lift the 12-month target from 360p to 620p.
N+1 Singer - Morning Song 21-03-2017
21 Mar 17
accesso Technology (ACSO LN) Full year results in line, but key trading months still ahead | Augean (AUG LN) Double digit growth in ’16, good start to ‘17 | Earthport (EPO LN) Interims show continued top line strength | Goals Soccer Centres (GOAL LN) Good momentum under new team. It’s now all about delivery | IQE (IQE LN) FY’16 results prompt further upgrades | Microsaic Systems (MSYS LN) Challenges in 2016, strategy remains in place | mporium Group (MPM LN) Funds raised to help execute strategy | RhythmOne (RTHM LN) Dawn of the independents | ScS Group (SCS LN) Strong progress on key growth initiatives albeit comps now toughen | Sinclair Pharma (SPH LN) FY results: EBITDA ahead, Instalift™ gaining pace | Vectura Group (VEC LN) FY (9-month) results
Or, helping a juggernaut turn on a dime
24 Mar 17
Sopheon has spent many years evolving a state-of-the-art platform allowing Enterprise customers to manage and monitor their pipelines of innovation. As this market matures and on the back of some major reference client wins, Sopheon’s Accolade product is beginning to see material success on a number of fronts. This note describes the marketplace, the technology, and the progress now being achieved.
Foundations for growth
21 Mar 17
accesso have released strong FY2016 Results which are marginally ahead of our expectations, this also follows the recent trading update at which it upgraded profitability figures. This is an impressive performance considering that 2016 has been a year of investment, not to mention the challenging trading conditions experienced in key summer months. This places accesso well for continued expansion in a significant and expanding global market.